Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer

NCT05751434 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT05751434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05751434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
February 10, 2023
Completion date
June 1, 2028
Enrollment
102 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate carcinoma, prostate adenocarcinoma, prostate cancer